Bio-Rad Laboratories, Inc. (BIO)
381.07
+1.04
(+0.27%)
USD |
NYSE |
Aug 24, 16:00
381.07
0.00 (0.00%)
After-Hours: 20:00
Bio-Rad Laboratories Total Assets (Quarterly) : 10.25B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.25B |
| March 31, 2026 | 9.79B |
| December 31, 2025 | 10.58B |
| September 30, 2025 | 9.696B |
| June 30, 2025 | 10.21B |
| March 31, 2025 | 9.527B |
| December 31, 2024 | 9.364B |
| September 30, 2024 | 10.60B |
| June 30, 2024 | 9.688B |
| March 31, 2024 | 12.61B |
| December 31, 2023 | 12.30B |
| September 30, 2023 | 11.90B |
| June 30, 2023 | 11.98B |
| March 31, 2023 | 13.67B |
| December 31, 2022 | 13.50B |
| September 30, 2022 | 12.06B |
| June 30, 2022 | 12.68B |
| March 31, 2022 | 14.37B |
| December 31, 2021 | 17.80B |
| September 30, 2021 | 19.95B |
| June 30, 2021 | 15.12B |
| March 31, 2021 | 13.93B |
| December 31, 2020 | 12.97B |
| September 30, 2020 | 12.02B |
| June 30, 2020 | 10.10B |
| Date | Value |
|---|---|
| March 31, 2020 | 8.684B |
| December 31, 2019 | 8.009B |
| September 30, 2019 | 7.177B |
| June 30, 2019 | 7.647B |
| March 31, 2019 | 6.863B |
| December 31, 2018 | 5.611B |
| September 30, 2018 | 6.719B |
| June 30, 2018 | 6.386B |
| March 31, 2018 | 6.215B |
| December 31, 2017 | 4.273B |
| September 30, 2017 | 4.186B |
| June 30, 2017 | 4.143B |
| March 31, 2017 | 3.953B |
| December 31, 2016 | 3.851B |
| September 30, 2016 | 4.020B |
| June 30, 2016 | 3.875B |
| March 31, 2016 | 3.753B |
| December 31, 2015 | 3.710B |
| September 30, 2015 | 3.666B |
| June 30, 2015 | 3.525B |
| March 31, 2015 | 3.326B |
| December 31, 2014 | 3.341B |
| September 30, 2014 | 3.386B |
| June 30, 2014 | 3.468B |
| March 31, 2014 | 3.441B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 113.17B |
| Agilent Technologies, Inc. | 13.06B |
| Danaher Corp. | 92.37B |
| Illumina, Inc. | 6.65B |
| Revvity, Inc. | 12.05B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.078B |
| Shareholders Equity (Quarterly) | 7.174B |
| Debt to Equity Ratio | 0.191 |
| Current Ratio | 3.142 |
| Net Debt Paydown Yield | -0.00% |